Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can assist in matching the needs of a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individualised treatment programs for the treatment and management of diabetic chest neurodegenerative disorders, usually including drug therapy, rehabilitation intervention, and regular follow-up, are developed.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule of changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of diabetic breast neurological disease.
The platform serves a team of domestic and foreign experts in the field of neural systems related to the International Medical Service System of China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.